2020-10-28T14:22:44-05:00 2019-12-31 ERNST & YOUNG US LLP 101 E WASHINGTON ST SUITE 910 PHOENIX AZ 85004 990 2019-01-01 251562714 THE INSTITUTE FOR TRANSFUSION MEDICINE % MARY K THOMPSON INST 4122097300 875 GREENTREE RD PC5 PITTSBURGH PA 15220 BHAVI SHAH GEN COUNSEL/ASST SEC 4806755503 2020-10-06 true PATRICK SHIELDS P01508556 6023223000 71.61.19.68 25553720203015000002 2020-10-27 P C705D473A83A388720F23E9C2AF7C73BD1A645A7 A4485482F404CA549E8704298C27367BFA2421D5 2019 2021-01-29 14:40:06Z X TANYA PERRY 6210 E OAK STREET SCOTTSDALE AZ 85257 5367258 false 5645 X WWW.ITXM.ORG X 1987 PA TO PROVIDE BEST IN CLASS BLOOD PRODUCTS AND CLINICAL SERVICES TO MEET THE NEEDS OF THE HEALTHCARE COMMUNITY, PATIENTS & OUR DONORS THROUGH ADVANCED TRANSFUSION MEDICINE PRACTICES. X 8 7 0 0 0 0 6907013 2351512 0 0 1595782 3015746 66432 0 8569227 5367258 2300468 1500000 0 0 3228339 0 0 0 0 -4661062 1509555 867745 3009555 7701482 2357703 53858965 0 77151688 0 -23292723 0 X ITXM'S MISSION IS TO PROVIDE BEST IN CLASS BLOOD PRODUCTS AND CLINICAL SERVICES TO MEET THE NEEDS OF THE HEALTHCARE COMMUNITY, PATIENTS AND OUR DONORS THROUGH ADVANCED TRANSFUSION MEDICINE PRACTICES. ITXM'S VISION IS TO BE THE PREMIER PROVIDER OF BLOOD TRANSFUSION PRACTICES BY DELIVERING INNOVATIVE INDUSTRY LEADING SOLUTIONS THAT ENSURE THE HIGHEST QUALITY PRODUCTS AND SERVICES, OPERATING EFFICIENCIES, DONOR SATISFACTON AND IMPROVED PATIENT CARE RESULTING IN THE ACHIEVEMENT OF OUR MISSION. ITXM'S MISSION AND VISION ARE SUPPORTED BY OUR VALUES OF STEWARDSHIP, INTEGRITY, ACCOUNTABILITY, RESPECT, EXCELLENCE AND INNOVATION. false true 2946772 1500000 0 THE INSTITUTE FOR TRANSFUSION MEDICINE (ITXM) IS THE "PARENT" ENTITY OF A HEALTH CARE SYSTEM DEDICATED TO PROVIDING BLOOD AND BLOOD-RELATED PRODUCTS AND SERVICES TO THE COMMUNITY. ITXM PROVIDES CERTAIN SERVICES FOR ITSELF AND FOR ITS AFFILIATED ORGANIZATIONS, INCLUDING ACCOUNTING, PURCHASING, HUMAN RESOURCES, QUALITY ASSURANCE, INFORMATION SYSTEMS, STRATEGIC PLANNING, EDUCATION, MAINTENANCE AND CORPORATE ADMINISTRTATION. THE CONSOLIDATION OF THESE SERVICES IN ONE ENTITY PROVIDES ECONOMIES OF SCALE AND EFFICIENCY SO AS TO IMPROVE THE DELIVERY OF COST EFFECTIVE HEALTH CARE TO THE COMMUNITY AT LARGE. ITXM PROVIDES TRAINING PROGRAMS FOR MEDICAL RESIDENTS AND FELLOWS IN THE AREAS OF TRANSFUSION MEDICINE AND COAGULATION. ITXM IS ALSO INVOLVED IN RESEARCH. ITXM MEDICAL STAFF PARTICIPATE IN IMPORTANT NATIONAL CLINICAL TRIALS IN BLOOD SAFETY, TRANSFUSION AND HEMOSTASIS. EDUCATING THE COMMUNITY IS ALSO A SERVICE PROVIDED BY ITXM. THROUGH AN ACTIVE SPEAKERS' BUREAU AND JOINT PROGRAMS WITH OTHER HEALTH CARE PROVIDERS, ITXM PRESENTS INFORMATION ON THE SAFETY OF BLOOD, BLOOD COMPONENT THERAPY, COAGULATION, THROMBOSIS AND OTHER PERTINENT TOPICS. SINCE IT IS ESTIMATED THAT TWO OUT OF FIVE PEOPLE WILL NEED A BLOOD TRANSFUSION AT SOME POINT IN THEIR LIVES, THESE EDUCATIONAL OPPORTUNITIES HELP CAREGIVERS, PATIENTS AND POTENTIAL RECIPIENTS OF THIS PRECIOUS RESOURCE UNDERSTAND THE BLOOD SUPPLY AND TRANSFUSION ISSUES AND ALLEVIATE SOME OF THE MISCONCEPTIONS RELATED TO TRANSFUSION MEDICINE. 0 0 0 2946772 true true false false false false false false false false false false false false true false true false false false false false false false false false true false true false false false false false false false false false false true false false true true true false false true 0 0 0 false false false false false false false false false false false false X 8 7 false false false false true true true true true false true true true true true true true true false false false IL PA X MARY K THOMPSON 6024143501 4405 E COTTON CENTER BLVD SUITE 12 PHOENIX AZ 85040 X DAVID GREEN DIRECTOR 1.0 39.0 X 0 732803 54355 BHAVI SHAH GENERAL COUNSEL/ASST SECRETARY 1.0 39.0 X 0 403388 56725 TANYA PERRY CFO 1.0 39.0 X 0 402285 32637 CHARLES WILCOX III DIVISION PRESIDENT 5.0 39.0 X 0 360752 36349 MARK J GIAQUINTO FORMER SECY/TREAS, PRES. BSF 0.0 0.0 X 0 308362 66146 JAMES R SCHRAITH DIRECTOR 1.0 1.0 X 0 37625 0 ROBERT S COLE CHAIR 1.0 1.0 X X 0 36000 0 JOHN S LEWIS DIRECTOR 1.0 1.0 X 0 29000 0 PATRICIA ABREGO-SANTUC VICE CHAIR 1.0 1.0 X X 0 27250 0 SUNNY P CHICO DIRECTOR 1.0 1.0 X 0 22500 0 PAUL E STANDER MD SECRETARY/TREASURER 1.0 1.0 X X 0 20500 0 RICHARD D MCHUGH MD DIRECTOR 1.0 1.0 X 0 0 0 0 2380465 246212 0 true true false CREATIVE TESTING SOLUTIONS 2424 W ERIE DRIVE TEMPE AZ 85282 BLOOD TESTING SVCS 12202201 1 0 0 0 2115491 236021 0 0 2351512 0 1364600 1364600 0 0 0 0 0 1651146 0 1651146 1651146 1651146 0 0 0 0 0 0 0 0 0 0 0 5367258 3015746 1500000 1500000 0 0 0 0 0 0 0 0 0 331716 331716 262469 262469 -4347 -4347 0 0 62783 62783 0 270000 270000 10783 10783 150 150 0 37937 37937 2440 2440 0 0 822893 822893 0 0 83 83 EMPLOYEE RECRUIT/DUES/RECOG 19922 19922 ITXM SHARED SERVICES -335400 -335400 MISCELLANEOUS 28126 28126 3009555 2946772 62783 0 0 0 8954533 0 157052 0 890476 0 0 0 0 0 0 0 0 0 0 0 0 0 1889188 0 0 0 41955680 0 0 0 0 0 12036 0 53858965 0 19417701 0 0 0 0 0 22140000 0 0 0 0 0 0 0 0 0 35593987 0 77151688 0 X -23292723 0 0 0 -23292723 0 53858965 0 X 2357703 4144847 16790173 X false true X true false X X 6 CENTRAL BLOOD BANK 251055312 10 true 0 0 LIFESOURCE BLOOD SERVICES 363492969 10 true 0 0 ITXM CLINICAL SERVICES 251839168 10 true 0 0 ITXM DIAGNOSTICS 030497690 10 false 0 0 HEMOPHILIA CENTER OF WESTERN PENNSYLVANIA 251562716 3 false 0 0 VITALANT 860098929 10 false 0 0 6 0 0 false false false false true false false true false false false false false false false false false false SCHEDULE A, PART IV, SECTION A, LINE 1 PER THE ORGANIZING DOCUMENTS, CENTRAL BLOOD BANK, LIFESOURCE, AND ITXM CLINICAL SERVICES ARE THE SUPPORTED ORGANIZATIONS. THROUGH ACQUISITIONS AND CORPORATE PRACTICE DECISIONS, ITXM'S OTHER SECTION 509(A)(1) AND 509(A)(2) AFFILIATES, ITXM DIAGNOSTICS, HEMOPHILIA CENTER OF WESTERN PENNSYLVANIA, AND VITALANT, FORMERLY BLOOD SYSTEMS, INC. HAVE BEEN ADDED AS SUPPORTED ORGANIZATIONS. SCHEDULE A, PART IV, SECTION A, LINE 5A VIRGINIA BLOOD SERVICES, EIN 54-0959121, WAS REMOVED AS A SUPPORTED ORGANIZATION. VIRGINIA BLOOD SERVICES WAS OFFICIALLY DISSOLVED ON DECEMBER 31, 2019. SCHEDULE A, PART IV, SECTION A, LINE 6 ITXM PROVIDED A GRANT TO THE UNIVERSITY OF PITTSBURGH DEPARTMENT OF MEDICINE. ALTHOUGH THIS ENTITY IS NOT A SUPPORTED ORGANIZATION OR A ORGANIZATION THAT ALSO SUPPORTS ONE OR MORE OF ITXM'S SUPPORTED ORGANIZATIONS, THEIR ACTIVITIES FURTHER THE EXEMPT MISSION OF ITXM'S 509(A)(1) AND 509(A)(2) SUBSIDIARIES. SCHEDULE A, PART IV, SECTION C, LINE 1 ITXM HAS THE SAME BOARD OF DIRECTORS AS FOUR OF ITS SUPPORTED ORGANIZATIONS: CENTRAL BLOOD BANK, LIFESOURCE BLOOD SERVICES, ITXM CLINICAL SERVICES AND ITXM DIAGNOSTICS. THE HEMOPHILIA CENTER OF WESTERN PENNSYLVANIA ("HCWP") HAS A DIFFERENT BOARD COMPOSITION BUT THE CFO OF ITXM, HCWP AND VITALANT WAS TANYA PERRY IN 2019. FURTHERMORE, HCWP'S ORGANIZING DOCUMENTS CONTAIN CERTAIN PROVISIONS PROVIDING THE ITXM BOARD WITH THE POWER TO APPOINT THE HCWP BOARD OF DIRECTORS AND TO REVIEW AND RATIFY HCWP'S ACTIVITIES AND MAJOR CORPORATE ACTIONS. ITXM'S ORGANIZING DOCUMENTS GIVE VITALANT THE POWER TO ELECT AND APPOINT ITXM'S BOARD OF DIRECTORS AND HAS THE POWER TO AMEND ITXM'S ARTICLES OF INCORPORATION AND BYLAWS. ACTIVITIES AND MAJOR CORPORATE ACTIONS. ITXM'S ORGANIZING DOCUMENTS GIVE VITALANT THE POWER TO ELECT AND APPOINT ITXM'S BOARD OF DIRECTORS AND HAS THE POWER TO AMEND ITXM'S ARTICLES OF INCORPORATION AND BYLAWS. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 0 X SCHEDULE D, PART X, LINE 2 THE INSTITUTE FOR TRANSFUSION MEDICINE WAS INCLUDED IN THE CONSOLIDATED AUDITED FINANCIAL STATEMENTS OF VITALANT. AT DECEMBER 31, 2019 THE COMPANY EVALUATED WHETHER IT HAD UNCERTAIN TAX POSITIONS THAT SHOULD BE RECOGNIZED OR DERECOGNIZED BASED ON A 'MORE LIKELY THAN NOT' THRESHOLD FOR TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN, INCLUDING THOSE TAX POSITIONS THAT WOULD NOT BE SUSTAINED UPON EXAMINATION IN ACCORDANCE WITH GUIDANCE RELATED TO ACS 740, ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES. THE TAX YEARS FOR THE COMPANY THAT ARE SUBJECT TO AUDIT BY THE IRS AND STATE DEPARTMENTS OF REVENUE ARE GENERALLY THE TAX YEARS ENDED DECEMBER 31, 2016, THROUGH THE CURRENT TAX YEAR, EXCEPT IN CERTAIN STATES WHERE THE OPEN TAX YEARS GENERALLY BEGIN WITH THE TAX YEAR ENDED DECEMBER 31, 2015. AS OF DECEMBER 31, 2019, THE COMPANY HAS NOT IDENTIFIED ANY SIGNIFICANT UNCERTAIN TAX POSITIONS THAT WOULD REQUIRE THE RECORDING OF A TAX LIABILITY. THE COMPANY DOES NOT ANTICIPATE A CHANGE IN UNCERTAIN TAX POSITIONS FOR THE 12 MONTHS FOLLOWING THE YEAR ENDED DECEMBER 31, 2019. AS OF DECEMBER 31, 2019, THE COMPANY HAD NO INTEREST OR PENALITIES WHICH QUALIFIED FOR EITHER RECOGNITION OR DISCLOSURE IN THE FINANCIAL STATEMENTS. true UNIVERSITY OF PITTSBURGH-DEPT OF MEDICINE 1218 SCAIFE HALL PITTSBURGH PA 15261 250965591 501(C)(3) 1500000 ESTABLISH A HEMOSTASIS CLINIC 1 SCHEDULE I, PART I, LINE 2 DOCUMENTATION FROM THE GRANT RECIPIENT IS OBTAINED THAT DEMONSTRATES COMPLIANCE WITH THE GRANT AGREEMENT. THIS DOCUMENTATION IS REVIEWED BY EXECUTIVE MANAGEMENT. false true false false false false false false false DAVID GREEN DIRECTOR 0 681103 0 40000 0 11700 0 21500 0 32855 0 787158 0 0 TANYA PERRY CFO 0 361585 0 30000 0 10700 0 15671 0 16966 0 434922 0 0 BHAVI SHAH GENERAL COUNSEL/ASST SECRETARY 0 362688 0 30000 0 10700 0 17924 0 38801 0 460113 0 0 CHARLES WILCOX III DIVISION PRESIDENT 0 341152 0 10000 0 9600 0 16754 0 19595 0 397101 0 0 MARK J GIAQUINTO FORMER SECY/TREAS, PRES. BSF 0 291670 0 16692 0 0 0 31956 0 34190 0 374508 0 0 SCHEDULE J, PART I, LINE 3 EFFECTIVE MARCH 1, 2017, THE INSTITUTE FOR TRANSFUSION MEDICINE ("ITXM") AMENDED ITS ARTICLES OF INCORPORATION AND BYLAWS SUCH THAT VITALANT, FORMERLY BLOOD SYSTEMS INC, BECAME ITXM'S SOLE CORPORATE MEMBER. THE COMPENSATION OF VITALANT'S CEO IS ESTABLISHED THROUGH THE FOLLOWING METHODS: COMPENSATION COMMITTEE, INDEPENDENT COMPENSATION CONSULTANT, COMPENSATION SURVEY OR STUDY AND APPROVAL BY THE COMPENSATION COMMITTEE. SCHEDULE J. PART I, LINE 4B THERE WERE NO TAXABLE DISTRIBUTIONS FROM THE SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN IN 2019 FOR THE PERSONS LISTED IN FORM 990, PART VII. THIS PLAN WAS FROZEN AS OF DECEMBER 31, 2011. SCHEDULE J, PART I, LINE 7 VITALANT HAS AN INCENTIVE PLAN FOR MANAGEMENT AND EXECUTIVES. AWARDS UNDER THE PROGRAM ARE AT THE DISCRETION OF THE BOARD OF TRUSTEES. THE PLAN MEASURES PERFORMANCE AGAINST MULTIPLE METRICS WHICH CARRY VARIOUS WEIGHTINGS, THE MOST HEAVILY WEIGHTED BEING QUALITY, SAFETY AND CUSTOMER SERVICE. TO ASSURE FINANCIAL STABILITY OF THE COMPANY, ONE OF THE METRICS IS ALSO A MEASUREMENT OF NET MARGIN FINANCIAL PERFORMANCE AS A PERCENT OF REVENUES. TRANSFER OF NET ASSETS DUE TO MERGER 2019-12-31 -9617680 BOOK VALUE 860098929 VITALANT 6210 E OAK STREET SCOTTSDALE AZ 85257 501(C)(3) true true false false true true true true true true SCHEDULE N,PART I EFFECTIVE JANUARY 1, 2020, THE INSTITUTE FOR TRANSFUSION MEDICINE ("ITXM") MERGED INTO VITALANT. AS A RESULT OF THE MERGER, ITXM TRANSFERRED ALL ITS ASSETS TO VITALANT. ITXM CONTINUES TO OPERATE SERVICES AND PROGRAMS AS PREVIOUSLY, NOW AS AN INTEGRAL PART OF THE OPERATIONS OF VITALANT. NO SEVERANCE OR CHANGE OF CONTROL PAYMENTS WERE MADE AS A RESULT OF THE MERGER. EMPLOYEES OF ITXM CONTINUED ON AS EMPLOYEES OF VITALANT. SCHEDULE N, PART I, LINE 2A CERTAIN ITXM DIRECTORS WERE DIRECTORS OF THE TRANSFEREE ORGANIZATION'S BOARD OF DIRECTORS BOTH BEFORE AND AFTER THE MERGER. SCHEDULE N, PART I, LINE 2B THE EMPLOYEES OF ITXM BECAME EMPLOYEES OF THE TRANSFEREE ORGANIZATION PRIOR TO THE MERGER. PART III, LINE 3 EFFECTIVE JANUARY 1, 2020, THE INSTITUTE FOR TRANSFUSION MEDICINE ("ITXM") MERGED INTO VITALANT. AS A RESULT OF THE MERGER, ITXM TRANSFERRED ALL ITS ASSETS TO VITALANT. ITXM CONTINUES TO OPERATE SERVICES AND PROGRAMS AS PREVIOUSLY, NOW AS AN INTEGRAL PART OF THE OPERATIONS OF VITALANT. PART VI, SECTION A, LINES 6, 7A AND 7B EFFECTIVE MARCH 1, 2017 THE INSTITUTE FOR TRANSFUSION MEDICINE ("ITXM")AMENDED ITS ARTICLES OF INCORPORATION AND BYLAWS SUCH THAT BLOOD SYSTEMS INC ("BSI") BECAME ITXM'S SOLE CORPORATE MEMBER. DURING THE PRIOR TAX YEAR BSI FORMALLY CHANGED IT'S NAME TO VITALANT. AS ITXM'S SOLE CORPORATE MEMBER, VITALANT HAS THE POWER TO ELECT AND APPOINT ITXM'S BOARD OF DIRECTORS AND CERTAIN RESERVED POWERS WITH RESPECT TO ITXM INCLUDING THE POWER TO AMENDED ITXM'S ARTICLES OF INCORPORATION AND BYLAWS; ITXM MERGER, CONSOLIDATION OR DISSOLUTION; AUTHORITY OVER DECISIONS RELATED TO ORGANIZATIONAL STRUCTURE, STRATEGIC GOALS, ECONOMIC OBJECTIVES, MAJOR OPERATING POLICIES, AND SIGNIFICANT FINANCIAL ACCOUNTING PRINCIPLES AND PRACTICES; SELECTION, EVALUATION, REPLACEMENT AND COMPENSATION OF ITXM SENIOR EXECUTIVE OFFICERS AND BOARD MEMBERS; SELECTION OF EXTERNAL CPAS TO EXAMINE AND AUDIT ITXM'S ANNUAL FINANCIAL STATEMENTS; SELECTION OF EXTERNAL ITXM LEGAL COUNSEL TO ADVISE THE ITXM BOARD; AND APPROVAL OF MAJOR ITXM PLANS, COMMITMENTS AND INITIATIVES. PART VI, SECTION B, LINE 11 THE 990 IS COMPLETED BY MANAGEMENT AND IS REVIEWED BY AN EXTERNAL, INDEPENDENT ACCOUNTING FIRM. THE 990 HAS BEEN REVIEWED BY EXECUTIVE LEADERSHIP AND A COPY HAS BEEN SENT TO VITALANT'S BOARD, AS THE SURVIVING ENTITY FROM THE MERGER, FOR THEIR REVIEW PRIOR TO FILING. PART VI, SECTION B, LINE 12C EACH YEAR, THE BOARD OF DIRECTORS AND SENIOR MANAGEMENT ARE REQUIRED TO SIGN AND RETURN A CONFLICT OF INTEREST FORM TO COMPANY COUNSEL. ANY CONFLICTS DISCLOSED ARE DISCUSSED IN EXECUTIVE SESSION WITH THE BOARD AND RESOLVED. IN ADDITION, IN PREPARATION FOR THE FORM 990 FILING, THE DIRECTORS, OFFICERS AND KEY EMPLOYEES IDENTIFIED ARE REQUIRED TO RESPOND TO A COMPREHENSIVE CONFLICT OF INTEREST AND FAMILY RELATIONSHIP QUESTIONAIRE. ANY CONFLICTS ARE DISCUSSED WITH THE BOARD AND DISCLOSED APPROPRIATELY ON THE FORM 990. PART VI, SECTION B, LINE 15 THE BOARD OF TRUSTEES OF VITALANT HAS A COMPENSATION AND HUMAN RESOURCES COMMITTEE WHOSE PURPOSE, AMONG OTHER THINGS, IS TO HIRE AN INDEPENDENT CONSULTING FIRM ONCE EVERY 2-3 YEARS TO PROVIDE DATA ON COMPETITIVENESS OF SALARIES AND BENEFITS FOR THE CEO, OFFICERS AND OTHER KEY EMPLOYEES OF THE CORPORATION. THIS PROCESS IS BEING CONDUCTED IN 2020. THE MEMBERS OF THE HUMAN RESOURCES AND COMPENSATION COMMITTEE OF THE BOARD ARE ALL INDEPENDENT TRUSTEES AND INCLUDE NO MEMBERS OF MANAGEMENT. THE RECOMMENDATONS OF THE COMMITTEE ARE REVIEWED BY THE ENTIRE BOARD PRIOR TO APPROVAL. COMPENSATION FOR THESE INDIVIDUALS IS SET AND APPROVED BY THE BOARD EACH YEAR. THE RESULTS OF THESE DISCUSSIONS, REVIEWS AND APPROVALS ARE DOCUMENTED IN THE EXECUTIVE SESSION MINUTES OF THE BOARD MEETINGS. PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. PART XI, LINE 9 TRANSFER OF VIRGINIA BLOOD SERVICES INTRA-COMPANY AND RETAINED EARNINGS TO ITXM $7,172,493 AND THE TRANSFER OF ITXM NET ASSETS, DUE TO MERGER, TO VITALANT $9,617,680. VITALANT 6210 EAST OAK STREET SCOTTSDALE AZ 85257 860098929 BLOOD BANK AZ 501(C)(3) 10 NA false BLOOD SCIENCE FOUNDATION 875 GREENTREE RD PARKWAY CENTER 5 PITTSBURGH PA 15220 251562715 FUNDRAISING PA 501(C)(3) 12D NA false BLOOD BANK SAN BERNARDINORIVERSIDE FDN PO BOX 1429 SAN BERNARDINO CA 92402 208911074 FUNDRAISING CA 501(C)(3) 12-TYPE I BBSBRC true GEISINGER BLOOD CTR PC5 875GRNTRE RD PGH PA 15220 364718005 BLOOD BANK PA ITXM RELATED 0 0 false 0 true CANYON STATE INSURANCE COMPANY PO BOX 1085113 S CHURCH ST GRAND CAYMAN CJ KY1-1102 981084327 CAPTIVE INS. CJ FOREIGN BIOCARE INC 6210 EAST OAK STREET SCOTTSDALE AZ 85257 813906720 PHARMA AZ C CORP TRANSFUSION TECHNOLOGY INC 102 CHESTNUT RIDGE ROAD MONTVALE NJ 07645 223494865 INACTIVE NJ C CORP false false true false false false false false false false false false true false false true true false false HEMOPHILIA CENTER OF WESTERN PA P 8500000 FMV BLOOD SCIENCE FOUNDATION C 2115491 FMV BLOOD SCIENCE FOUNDATION Q 1077199 FMV BIOCARE INC P 33288809 FMV SCHEDULE R, PART III THE PENNSYLVANIA DEPARTMENT OF STATE TERMINATED GEISINGER BLOOD CENTER EFFECTIVE OCTOBER 10, 2019.